DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Capsaicin on Salty Gustatory Cortices

Information source: Third Military Medical University
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Healthy Volunteer

Intervention: Capsaicin (Dietary Supplement)

Phase: Phase 4

Status: Completed

Sponsored by: Zhiming Zhu

Summary

Excess dietary salt intake is closely associated with the development of hypertension and cardiocerebral vascular diseases. Preference of high salt diet might involve salty gustatory cortices change. This study focuses on examining the neuroimaging changes of salty gustatory cortices under different concentration of NaCl solution with or without capsaicin intervention through brain PET/CT scan.

Clinical Details

Official title: Effects of Capsaicin on Salty Gustatory Cortices in Human

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science

Primary outcome: Neuroimaging changes of salty gustatory cortices

Detailed description: Hypertension and its related complications are common health problems that can lead to multiple organ damage and death. Excessive salt intake plays an important role in the development of hypertension. The experimental design is a randomized, double-blind, interventional study to investigate the neuroimaging changes of salty gustatory cortices under different concentration of NaCl solution with or without capsaicin intervention through brain PET/CT scan.

Eligibility

Minimum age: 18 Years. Maximum age: 55 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Age ≥ 18 years and ≤ 55 years.

- Willing and able to provide written informed consent.

- Willing and able to comply with all study procedures.

Exclusion Criteria:

- Diabetes.

- Hypertension.

- High basic metabolic rate, tumor, epilepsia.

- Hypogeusia or loss due to neural system disease or oral and digestive disease.

- Capsaicin allergy and poor compliance.

- Recently oral diuretics and participate in other pharmacological experiment in 3

months.

- Acute infection, cancer, serious arrhythmias, drug or alcohol abuse.

- Currently have cold, fever, acidosis, dehydration, diarrhea, vomiting during the

study.

- Unwilling or unable to communication due to the dysnoesia and language disorders.

- Severe neural or psychiatric diseases that would preclude fully understand and

corporation in the study.

- History of allergic reaction attributed to 18F-FDG.

- Pregnancy or lactation.

Locations and Contacts

Daping Hospital, The Third Military Medical University, Chongqing, Chongqing 400042, China
Additional Information

Starting date: May 2013
Last updated: December 15, 2013

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017